New hope for kids with Drug-Resistant TB: bedaquiline study shows promise
NCT ID NCT02906007
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study looked at how safe and effective the drug bedaquiline is for children and teens with a hard-to-treat form of tuberculosis (TB) that is resistant to the antibiotic rifampin. The trial included 54 participants, some of whom also had HIV. Researchers monitored side effects and drug levels in the blood over 24 weeks to find the right dose for different age groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Desmond Tutu TB Centre - Stellenbosch University (DTTC-SU) CRS
Cape Town, Western Cape, 7505, South Africa
-
Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS
Port-au-Prince, HT-6110, Haiti
-
PHRU Matlosana CRS
Klerksdorp, North West, 2574, South Africa
-
Sizwe CRS
Johannesburg, Gauteng, South Africa
Conditions
Explore the condition pages connected to this study.